Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: J Clin Pharmacol. 2020 Feb 12;60(6):744–750. doi: 10.1002/jcph.1575

Table 3.

Montreal Cognitive Assessment (MoCA) and Unified Parkinson’s Disease Rating Scale (UPDRS parts I-IV) Scores Before and After Ursodeoxycholic Acid (UDCA) Treatment

Subject MoCA Score (Baseline) MoCA Score (Post-UDCA Treatment) MoCA Change From Baseline UPDRS Score (Baseline) UPDRS Score (Post-UDCA Treatment) UPDRS Change From Baseline

1 25 27 2 45 32 −13
2 29 30 1 29 28 −1
3 26 28 2 50 46 −4
4 28 28 0 46 51 5
5 25 30 5 54 44 −10
Mean 26.6 28.6 2 44.8 40.2 −4.6
Standard Deviation 1.8 1.3 1.9 9.5 9.8 7.2